×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Nicotinamide Riboside
therapeutic
3,043 words
KG: Nicotinamide Riboside
2026-03-21
kind:therapeutic
section:therapeutics
state:published
topic:nad
topic:mitochondria
topic:alzheimers
topic:parkinsons
Contents
Nicotinamide Riboside
💊
Therapeutic Info
Name
Nicotinamide Riboside
Summary
Page for Nicotinamide Riboside
Knowledge Graph
Related Hypotheses (30)
Microbial Inflammasome Priming Prevention
Score: 0.58
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
PARP1 Inhibition Therapy
Score: 0.58
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P
Score: 0.64
Digital Twin-Guided Metabolic Reprogramming
Score: 0.61
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
Ferroptosis Inhibition for α-Synuclein Neuroprotection
Score: 0.55
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
NLRP3/Mitophagy Coupling Modulation
Score: 0.52
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.51
Early Proteasome Restoration Therapy
Score: 0.50
White Matter Oligodendrocyte Protection via CXCL10 Inhibitio
Score: 0.48
TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.47
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47
Cryptic Exon Silencing Restoration
Score: 0.46
HDAC3-Selective Inhibition for Clock Reset
Score: 0.46
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.45
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.44
Mitochondrial Transfer Pathway Enhancement
Score: 0.44
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.43
Mitochondrial NAD+ Salvage Enhancement
Score: 0.43
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.41
Mitochondrial RNA Granule Rescue Pathway
Score: 0.40
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40
FOXO3-Longevity Pathway Epigenetic Reprogramming
Score: 0.39
SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.39
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc
Score: 0.60
Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Ove
Score: 0.59
Show 25 more
Related Analyses (12)
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Show 7 more
Related Experiments (27)
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40
Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40
Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40
DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40
Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40
NAD depletion effects on monocyte/macrophage differentiation
exploratory · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
FK866 treatment in DSS-induced colitis mouse model
validation · proposed · Score: 0.90
FK866 in azoxymethane/DSS colitis-associated cancer model
validation · proposed · Score: 0.85
Epigenetic Clocks in Neurodegeneration — Causal Drivers or P
validation · proposed · Score: 0.40
Normal Aging to Alzheimer's Disease Transition Trigger — Ide
validation · proposed · Score: 0.40
Tet2 modulation in Aβ42-injured mouse hippocampal neurons
exploratory · proposed · Score: 0.90
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Sirtuin Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Show 22 more